Desipramine in the treatment of adolescents with attention deficit disorder



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Gastfriend, D. R.
	Articles by Jellinek, M. S.
	Search for Related Content



	PubMed Citation
	Articles by Gastfriend, D. R.
	Articles by Jellinek, M. S.

Am J Psychiatry 1984; 141:906-908
Copyright © 1984 by American Psychiatric Association

REGULAR ARTICLES

Desipramine in the treatment of adolescents with attention deficit disorder

DR Gastfriend, J Biederman and MS Jellinek

Twelve adolescents with attention deficit disorder were treated with desipramine in an open trial to assess its efficacy and safety. Eleven patients improved within 1 month, and improvement was sustained for 6- 12 months without significant adverse effects in nine patients.

This article has been cited by other articles:

L. H. McCormick, G. T. Rizzuto, and H. B. Knuckles
A Pilot Study of Buspirone in Attention-Deficit Hyperactivity Disorder
Arch Fam Med, January 1, 1994; 3(1): 68 - 70.
[Abstract] [PDF]

L. Hersher
Attention Deficit Disorder Is a Chronic Problem
Arch Pediatr Adolesc Med, March 1, 1987; 141(3): 239 - 240.
[Abstract] [PDF]

Get information about faster international access.